BLFS
BioLife Solutions, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +14.3% ·
share flow +23.1% ·
net new positions +12.5%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | +15 | 26.70M | $753.05M | +17 | −2 |
| Q1 2026 | 70 | -3 | 26.13M | $498.41M | +5 | −8 |
| Q4 2025 | 72 | -4 | 28.22M | $682.48M | — | −4 |
| Q3 2025 | 16 | +2 | 14.03M | $358.03M | +2 | — |
| Q2 2025 | 11 | +1 | 11.70M | $252.03M | +2 | −1 |
| Q1 2025 | 7 | -1 | 2.99M | $68.26M | — | −1 |
| Q4 2024 | 8 | +1 | 4.22M | $109.55M | +1 | — |
| Q3 2024 | 6 | 0 | 1.96M | $49.08M | +1 | −1 |
| Q2 2024 | 6 | — | 1.99M | $42.59M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.47M | — | $38.14M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Millennium Management ✦ | 1.15M | +49.1% | $29.73M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 833.43K | -1.1% | $21.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 833.43K | -1.1% | $21.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Point72 Asset Management ✦ | 428.10K | New | $11.11M | 0.0% | New | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 289.59K | +9.1% | $7.52M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 289.59K | +9.1% | $7.52M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 21.10K | -61.2% | $547,756 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 19.44K | +15.6% | $505,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Gotham Asset Management ✦ | 13.80K | +11.5% | $358,248 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $11.11M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 186 holders, 49.64M shares, $817.90M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.